Cortical Excitability Using Transcranial Magnetic Stimulation and Neuronavigation Device
- Conditions
- Healthy Volunteers
- Registration Number
- NCT02596789
- Lead Sponsor
- University Hospital, Grenoble
- Brief Summary
This study has two main goals :
* to investigate the impact of aging on cortical excitability (CE)
* to investigate the impact of "state dependency" on CE, using a cognitive task and an emotional one.
A Neuronavigation system of transcranial magnetic stimulation is used, and electromyographic response are recorded.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 75
- male or female
- age 18-75
- signed informed consent
- normal physical examination
- less 18 or more 75 years of age
- contra indication to TMS: epilepsia or seizures, metallic head devices, cardiac pacemaker, pregnancy, jet lag or severe insomnia the night before
- severe physical disease
- treatment with psychotropic drugs
- overt psychiatric disease
- alcohol consumption before the examination
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Amplitudes of Motor evoked Potentials (µV) for ICI and ICF. Participants will be followed for an expected average of one month Motor Evoked Potential (MEP) from the first dorsal interosseous are register during the stimulations.
Intracortical Inhibition (ICI) and Facilitation (ICF) are a paired-pulse TMS measure of cortical excitability. A short Interval interstimuli (2ms) leads to a cortical inhibition, which reflects the GABAergic neurotransmission; whereas a longer interval interstimuli leads to a cortical facilitation, which reflects glutamatergic neurotransmission.Durations of Cortical Silent Period (ms) Participants will be followed for an expected average of one month Cortical Silent Period (CSP) is a single-pulse TMS measure of cortical inhibition, stimulations are applied while subjects are exerting a muscular contraction of the thum-index pinch and lead to a muscular cancellation. Duration of this silence is measured.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Department of Psychiatry & Neurology - University Hospital Grenoble
🇫🇷Grenoble, France
Department of Psychiatry & Neurology - University Hospital Grenoble🇫🇷Grenoble, France